This document describes a study that used flow cytometry to detect Leishmania parasites inside infected macrophages. Leishmania are single-celled parasites that infect humans and cause diseases like cutaneous and visceral leishmaniasis. The study infected mouse macrophages with L. major and L. infantum and used an anti-Leishmania antibody with fluorescent tagging to detect the parasites via flow cytometry. The results showed that the antibody attached to the surface of both parasite species and flow cytometry could distinguish between infected and uninfected macrophages, though separation was incomplete. This technique has potential for detecting Leishmania infection.
A brief exploration of the way some modern viruses act and ancient viruses have acted to benefit their hosts - particularly humans - today and through evolutionary history, by various means (such as targeted destruction of pathogenic bacteria and introduction of new genetic material).
This presentation may help you understand the malarial infection. this includes major points that are necessary to understand it's route of infection and control.
Washington Global Health Alliance Discovery Series
Robert Sinden, PhD
July 28, 2008
'Understanding Malaria Development in the Mosquito, and its Pivotal Role in the Formulation of Effective Control Strategies'
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
Gene Olinger, USAMRIID, Fort Detrick USA, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Protective Immune Reponses to Ebola Virus
A brief exploration of the way some modern viruses act and ancient viruses have acted to benefit their hosts - particularly humans - today and through evolutionary history, by various means (such as targeted destruction of pathogenic bacteria and introduction of new genetic material).
This presentation may help you understand the malarial infection. this includes major points that are necessary to understand it's route of infection and control.
Washington Global Health Alliance Discovery Series
Robert Sinden, PhD
July 28, 2008
'Understanding Malaria Development in the Mosquito, and its Pivotal Role in the Formulation of Effective Control Strategies'
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
Gene Olinger, USAMRIID, Fort Detrick USA, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Protective Immune Reponses to Ebola Virus
mRNA rather than DNA may become the nucleotide framework for new classes of drugs and vaccines. Exciting preclinical results in prophylaxis and initial clinical data in oncology suggest that mRNA technology could be translated into improvements in lung cancer and other diseases.
This slide is about the basics of mRNA-based therapy. The content includes: definition of mRNA, timeline of mRNA therapeutics, action mechanism and development strategies of mRNA drugs, therapeutic mRNA applications, and the related services provided by Creative Biolabs.
ProImmune Antigen Characterization Summit Paul Mossamandacturner
Paul Moss, School of Cancer Sciences, Birmingham UK, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Cytomegalovirus and Cancer-specific Immunity
Viral Based Gene Delivery System for Car-t Cell Engineering Creative-Biolabs
A brief introduction about lentiviral vector gene delivery system and its application in CAR-T cell construction. Creative Biolabs offers high quality lentivirus based CAR gene delivery service to help with your CAR-T cell development projects.
Suicide gene therapy is based on the delivery of a gene encoding a cytotoxic protein into tumor cells.
For this, there are two possible strategies:
1. Indirect gene therapy using enzyme-activated pro-drug, which allows the conversion of a pro-drug into a lethal drug into cells.
2. Direct gene therapy using a toxin gene, whose expression can change the stability of the cell membrane and reduce the viability of tumor cells, or correct mutated pro-apoptotic genes, generally tumor suppressor genes that in normal condition induce cell suicide.
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
Clinical molecular diagnostics for drug guidanceNikesh Shah
1. Be familiar with next generation molecular diagnostic techniques that can provide guidance in clinical decision making
2. Identify the utility of these diagnostic approaches with some examples
3. Be aware of the challenges that exist in implementing these tools as part of the routine clinical decision making process, especially in resource limited settings
COVID-19: Biology, Transmission, and DetectionAlejandroAlRuiz
A short PowerPoint for those interested in learning more about the biology of SARS-CoV-2, how it is transmitted, and what are the current methods of detection. This PowerPoint also demonstrates how we can begin to teach about SARS-CoV-2 in our classrooms.
Enzybiotics New era of antimicrobials.pptMedhavi27
In the current era of emergence of resistance against traditionally used antibiotics researchers are trying to devise treatment strategies to combat resistant infections. Phage derived lysins are such effective and alternative antimicrobials which kill bacteria with very low chances of developing resistance.
JC Virus of the CNS classically presents as progressive multifocal leukoencephalopathy, but on rare occasion can manifest as septic meningitis. Slides compares the presentation, workup and treatment in both forms.
mRNA rather than DNA may become the nucleotide framework for new classes of drugs and vaccines. Exciting preclinical results in prophylaxis and initial clinical data in oncology suggest that mRNA technology could be translated into improvements in lung cancer and other diseases.
This slide is about the basics of mRNA-based therapy. The content includes: definition of mRNA, timeline of mRNA therapeutics, action mechanism and development strategies of mRNA drugs, therapeutic mRNA applications, and the related services provided by Creative Biolabs.
ProImmune Antigen Characterization Summit Paul Mossamandacturner
Paul Moss, School of Cancer Sciences, Birmingham UK, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Cytomegalovirus and Cancer-specific Immunity
Viral Based Gene Delivery System for Car-t Cell Engineering Creative-Biolabs
A brief introduction about lentiviral vector gene delivery system and its application in CAR-T cell construction. Creative Biolabs offers high quality lentivirus based CAR gene delivery service to help with your CAR-T cell development projects.
Suicide gene therapy is based on the delivery of a gene encoding a cytotoxic protein into tumor cells.
For this, there are two possible strategies:
1. Indirect gene therapy using enzyme-activated pro-drug, which allows the conversion of a pro-drug into a lethal drug into cells.
2. Direct gene therapy using a toxin gene, whose expression can change the stability of the cell membrane and reduce the viability of tumor cells, or correct mutated pro-apoptotic genes, generally tumor suppressor genes that in normal condition induce cell suicide.
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
Clinical molecular diagnostics for drug guidanceNikesh Shah
1. Be familiar with next generation molecular diagnostic techniques that can provide guidance in clinical decision making
2. Identify the utility of these diagnostic approaches with some examples
3. Be aware of the challenges that exist in implementing these tools as part of the routine clinical decision making process, especially in resource limited settings
COVID-19: Biology, Transmission, and DetectionAlejandroAlRuiz
A short PowerPoint for those interested in learning more about the biology of SARS-CoV-2, how it is transmitted, and what are the current methods of detection. This PowerPoint also demonstrates how we can begin to teach about SARS-CoV-2 in our classrooms.
Enzybiotics New era of antimicrobials.pptMedhavi27
In the current era of emergence of resistance against traditionally used antibiotics researchers are trying to devise treatment strategies to combat resistant infections. Phage derived lysins are such effective and alternative antimicrobials which kill bacteria with very low chances of developing resistance.
JC Virus of the CNS classically presents as progressive multifocal leukoencephalopathy, but on rare occasion can manifest as septic meningitis. Slides compares the presentation, workup and treatment in both forms.
Optimizing antimicrobial therapy for hospitalized pneumonia: Focus on PK/PD p...WAidid
Professor Blasi slideset is about the optimization of antimicrobial therapy for pneumonia and it underlines how the appropriate early antibiotic therapy reduces mortality rates in patients with bloodstream infection.
The slides give general description of gene therapy and some applications, factors to be considered when applying this method, viral vectors and non viral vectors applications and finally some successses of gene therapy
Alan Lesniewicz Memorial Lecture at UIC - July 2015Cassandra Quave
This is the keynote lecture given at the University of Illinois at Chicago Garden Walk event in the department of Pharmacognosy. The objectives of the talk were:
·Discuss the role of medical ethnobotany in drug discovery efforts
·Explore state-of-the-art research techniques that examine the activity of botanical natural products with next generation antibiotic discovery efforts focused on “alternative targets”, such as bacterial communication systems
·Provide examples of current research underway by her group both in the field (especially through fieldwork in the Mediterranean) and the lab (natural product research on multidrug resistant bacteria).
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes. Given almost any substance, it is possible to produce monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology, and medicine. When used as medications, non-proprietary drug names end in -mab and many immunotherapy specialists use the word mab anacronymically.
Lymphoproliferative disorders DR MASOUD 2022.pptxmasoud53
overview presentation about lymphoproliferative disorders for medicine students. it is with easy pattern. it covers all subjects of this disease, either malignant or benign types
4. ♦ Recognition of lipophosphoglycan (LPG)
♦ Promastigote engulfment
♦ Leishmania live in vesicles
protected from:
• Antibodies
• Killer T cells
♦ Inhibition of phagosome-endosome fusion
♦ Recognition of lipophosphoglycan (LPG)
♦ Promastigote engulfment
♦ Leishmania live in vesicles
protected from:
• Antibodies
• Killer T cells
♦ Inhibition of phagosome-endosome fusion
Immunological Subversion
5. Distribution
♦ 98 endemic countries
• 0.2 to 0.4 million new VL cases; 0.7 to 1.2 million new CL
cases each year worldwide
♦ Restricted to tropical and temperate regions
7. Predictions and Hypotheses
♦ Predictions – The intracellular staining will
enable detection of Leishmania species inside
macrophages
♦ Alternative hypothesis – flow cytometry will
detect Leishmania
♦ Null hypothesis – flow cytometry will not detect
Leishmania
10. Experimental Design
♦ Macrophage Cells
• Mouse cell line J774A.1
♦ Leishmania species
• L. major - cutaneous
• L. infantum - visceral
11. Experimental Design
♦ L. major and L. infantum treatments:
• Control without fluorescein isothiocyanate
(FITC)
• Experimental group with FITC
♦ Anti-Leishmania (GP-63) Monoclonal
Antibody
♦ Visualized parasites following
flow acquisition
13. FSC & SSC Results
Figure 1 Control J774 macrophages Figure 2 Macrophages infected with
L. major
Figure 3 Macrophages infected with
L. infantum
Figure 4 Macrophages infected with L.
infantum mixed with control
Figure 1 Control J774 macrophages Figure 2 Macrophages infected with
L. major
Figure 3 Macrophages infected with
L. infantum
Figure 4 Macrophages infected with L.
infantum mixed with control
17. Parasite Flow Results
Figure 1 L. major: (left) without FITC and
(right) with FITC
Figure 2 L. infantum: (left) without FITC and
(right) with FITC
Figure 3 Histogram plot of L. major: (left)
without FITC and (right) with FITC
Figure 4 Histogram plot of L. infantum: (left)
without FITC and (right) with FITC
FL1 FL1
FL3
FL3
FL1 FL1 FL1 FL1
FL3
FL3
FL1FL1
18. Intracellular Staining Results
Figure 6 L. major infected macrophages
Figure 7 L. infantum infected macrophages Figure 8 L. infantum infected
macrophages mixed with control
Figure 5 Control macrophagesFigure 5 Control macrophages Figure 6 L. major infected macrophages
Figure 7 L. infantum infected macrophages Figure 8 L. infantum infected
macrophages mixed with control
19. Conclusions
♦ Anti-leishmania antibody does attach to the
major surface protease of L. infantum and L.
major
♦ L. infantum binds with higher specificity to
antibody than L. major
♦ Incomplete separation of infected versus
uninfected macrophages
20. Acknowledgements
• Dr. Gabrielle Stryker –
Mentor
• Dr. Blaise Dondji –
Leishmania expert & donor
• W. M. Keck Foundation and
Murdock Fund
• Mark Young – FlowJo
Wizard
• Eric Foss –
Photomicroscopy
Technician
• Heidi Anderson
• Mercedes Cheslock
21. References
Colomer - Gould, V., L. G. Quintao, J. Keithly, N. Nogueira. (1985). A
common surface antigen on amastigoes and promastigotes of
Leishmania species. J. Exp. Med., 162(902).
Desjardins, M., & Descoteaux, A. (1997). Inhibition of phagolysosomal
biogenesis by the Leishmania lipophosphoglycan. The Journal of
Experimental Medicine, 185(12), 2061–2068.
Russel, D.G., and H. Wilhelm. (1986). The involvement of the major
surface glycoprotein (gp63) of Leishmania in attachment to
macrophages. J. Immunol., 136(2616).
Kram, D., Thale, C., Kolodziej, H., and Kiderlen, A. (2008).
Intracellular parasite kill: Flow cytometry and NO detection for rapid
discrimination between anti-leishmanial activity and macrophage
activation. Journal of Immunological Methods, 333(20).
Leishmaniasis is transmitted by the bite of infected female phlebotomine sandflies. The sandflies inject the infective stage (i.e., promastigotes) from their proboscis during blood meals . Promastigotes that reach the puncture wound are phagocytized by macrophages and other types of mononuclear phagocytic cells. Progmastigotes transform in these cells into the tissue stage of the parasite (i.e., amastigotes) , which multiply by simple division and proceed to infect other mononuclear phagocytic cells . Parasite, host, and other factors affect whether the infection becomes symptomatic and whether cutaneous or visceral leishmaniasis results. Sandflies become infected by ingesting infected cells during blood meals (, ). In sandflies, amastigotes transform into promastigotes, develop in the gut (in the hindgut for leishmanial organisms in the Viannia subgenus; in the midgut for organisms in the Leishmania subgenus), and migrate to the proboscis .
The parasites cause a complex of diseases called leishmaniasis
We show that LPG repeating units enable Leishmania to inhibit the phagosome-endosome fusion process efficiently, thereby suggesting a survival strategy during their differentiation into amastigotes.
L inhabit mo intracellularly which protects from other immune respones.